2Silberstein EB.Advanced in our understanding of the treatment of painful bone metastases[J].J Nucl Med,2000;41(4):655-657.
3Tullgren O,Grimfors G,Holm G,et al .Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease[J].Cancer,1991;68(15):768-775.
4Whittington R,Faulds D.Interleukin-2:A view of its pharmacological properties and therapeutic use in patients with cancer[J].Drugs,1993;46(3):446-514.
5Seki N,Hayakawa Y,Brooks AD,et al .Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosisis an important endogenous mechanism for resistance to liver metastases in murine renal cancer[J].Cancer Res,2003;63(1):207-213.
6Hafner M,Orosz P,Kruger A,et al .TNF promotes metastases by impairing natural killer cell activity[J].Int J Cancer,1996;66(3):388-392.
7Nakazaki H.Preoperative and postoperative cytokines in patients with cancer[J].Cancer,1992;70(3):709-713.
8Takagi K,Tomita K,Fukushima Y,et al .Endogenous TNF inducibility and prognosis of colorectal cancer[J].Anticancer Res,1998;18(6A):4435-4441.
9Kimura K,Bowen C,Kpiegel S,et al .TNF-α sensitizes prostate cancer cells to gamma-irradiation induced apoptosis[J].Cancer Res,1999;59(7):1606-1614.
